Sowell Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Buy
552
+103
+23% +$57.8K 0.01% 884
2026
Q1
$252K Buy
449
+25
+6% +$16K 0.01% 906
2025
Q4
$287K Buy
424
+30
+8% +$20.4K 0.01% 852
2025
Q3
$252K Buy
+394
New +$239K 0.01% 889
2021
Q2
Sell
-618
Closed -$330K 1535
2021
Q1
$330K Buy
618
+64
+12% +$32.1K 0.01% 804
2020
Q4
$277K Buy
554
+54
+11% +$24.2K 0.01% 728
2020
Q3
$197K Sell
500
-94
-16% -$34.8K 0.01% 732
2020
Q2
$196K Buy
594
+467
+368% +$135K 0.01% 730
2020
Q1
$31K Sell
127
-52
-29% -$13.6K ﹤0.01% 1231
2019
Q4
$47K Sell
179
-3,835
-96% -$1.01M ﹤0.01% 1166
2019
Q3
$1.09M Buy
+4,014
New +$1.12M 0.09% 238

Other funds holding IDXX

Sowell Financial Services's IDXX Position: Q2 2026 in Review

Sowell Financial Services increased its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, buying an estimated $57.8K and bringing the position to 552 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #884.

Sowell Financial Services first reported a position in IDXX in Q3 2019 and has held it in 11 quarters since. The position peaked at $1.09M in Q3 2019. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sowell Financial Services held 552 shares of Idexx Laboratories worth $291K as of Q2 2026.
  • Sowell Financial Services bought 103 Idexx Laboratories shares in Q2 2026, an estimated $57.8K.
  • Idexx Laboratories made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #884 holding.
  • Sowell Financial Services first reported a position in Idexx Laboratories in Q3 2019 and has held it in 11 quarters since.
  • Sowell Financial Services's Idexx Laboratories position peaked at $1.09M in Q3 2019.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.